(MedPage Today) -- Merck's copycat has similar HbA1c effect in trial
via Biosimilar Insulin Glargine Matches Up With Lantus in Phase III
by
Showing posts with label Biosimilar Insulin Glargine Matches Up With Lantus in Phase III. Show all posts
Showing posts with label Biosimilar Insulin Glargine Matches Up With Lantus in Phase III. Show all posts
Tuesday, June 14, 2016
Subscribe to:
Posts (Atom)